Perspective Therapeutics, Inc. (CATX)
$2.66-1.85%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $205M
- Beta
- 1.85
- P/E (TTM)
- -1.51
- Short % float
- 32.92%
- Days to cover
- 5.5
- SI change
- -27.3%
- 1W
- -3.62%
- 1M
- -3.97%
- vs SPY 1W
- -4.78%
- vs SPY 1M
- -6.96%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CATX?
- LOPJLB’s latest quantitative signal on Perspective Therapeutics, Inc. (CATX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CATX in?
- Perspective Therapeutics, Inc. (CATX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Perspective Therapeutics, Inc. (CATX) do?
- Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle â from development and manufacturing to sales and marketing â of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship prod…